ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 37 filers reported holding ASTRIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,330,000 | +62531.6% | 1,000,000 | 0.0% | 0.47% | -46.7% |
| Q1 2023 | $13,300 | -45.9% | 1,000,000 | -39.4% | 0.88% | -46.7% |
| Q4 2022 | $24,569 | -99.8% | 1,650,000 | +37.5% | 1.64% | +116.9% |
| Q3 2022 | $10,848,000 | +1105.3% | 1,200,000 | +300.0% | 0.76% | +1014.7% |
| Q2 2022 | $900,000 | -55.3% | 300,000 | 0.0% | 0.07% | -56.1% |
| Q1 2022 | $2,013,000 | -32.4% | 300,000 | -45.7% | 0.16% | -12.4% |
| Q4 2021 | $2,980,000 | -39.0% | 552,903 | 0.0% | 0.18% | -11.1% |
| Q3 2021 | $4,888,000 | – | 552,903 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |